These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Diabetes-Technology and the Environment: What Do We Have to Consider? Heinemann L J Diabetes Sci Technol; 2023 May; 17(3):607-610. PubMed ID: 36540008 [No Abstract] [Full Text] [Related]
7. Continuous subcutaneous insulin infusion therapy: A primer on insulin pumps. Potti LG; Haines ST J Am Pharm Assoc (2003); 2009; 49(1):e1-13; quiz e14-7. PubMed ID: 19196588 [TBL] [Abstract][Full Text] [Related]
8. Current insulin infusion set failure criteria may be too stringent for real-life settings and may skew infusion set failure outcomes in extended-wear infusion set studies. Kastner JR; Poettler T; Kopanz J; Hochfellner DA; Romey M; Baumann PM; Muchmore D; Strasma PJ; Mader JK Diabetes Obes Metab; 2023 Apr; 25(4):1106-1111. PubMed ID: 36482830 [No Abstract] [Full Text] [Related]
9. Air occlusion in insulin pumps of children and adolescents with type 1 diabetes. Knoll MM; Vazifedan T; Gyuricsko E J Pediatr Endocrinol Metab; 2020 Feb; 33(2):179-184. PubMed ID: 31812947 [TBL] [Abstract][Full Text] [Related]
13. [Glucose sensors, insulin pumps and smart pens are growing together - A clinical update to modern diabetes technology]. Gehr B MMW Fortschr Med; 2020 Dec; 162(21-22):69-75. PubMed ID: 33319293 [No Abstract] [Full Text] [Related]
14. Clinical Efficacy of Two Different Methods to Initiate Sensor-Augmented Insulin Pumps: A Randomized Controlled Trial. Moreno-Fernandez J; Gómez FJ; Gálvez Moreno MÁ; Castaño JP J Diabetes Res; 2016; 2016():4171789. PubMed ID: 28004007 [No Abstract] [Full Text] [Related]
15. Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT. Blair J; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes D; Gamble C Health Technol Assess; 2018 Aug; 22(42):1-112. PubMed ID: 30109847 [TBL] [Abstract][Full Text] [Related]
16. Increased Usage of Insulin Pump Functions Not Associated With Improved HbA1c in Children and Adolescents With Type 1 Diabetes Mellitus. Sandberg H; Anderberg P; Forssell H; Ovhed I; Berglund J J Diabetes Sci Technol; 2016 Jul; 10(4):997-8. PubMed ID: 26721525 [No Abstract] [Full Text] [Related]
18. Similar A1C outcomes in type 1 diabetic patients undergoing intensive diabetes management with preprandial rapid-acting insulin and either CSII or glargine. Harmel AP; Mathur R Diabetes Care; 2004 Jan; 27(1):272-3. PubMed ID: 14694001 [No Abstract] [Full Text] [Related]
19. Perceptions and experiences of adult patients with type 1 diabetes using continuous subcutaneous insulin infusion therapy: Results of an online survey. Taleb N; Messier V; Ott-Braschi S; Ardilouze JL; Rabasa-Lhoret R Diabetes Res Clin Pract; 2018 Oct; 144():42-50. PubMed ID: 30077691 [TBL] [Abstract][Full Text] [Related]
20. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections. Bode BW Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]